Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Herbert

Showing results (231-240 of 269) with videos related to

Pageof 27
Sort By:
Biorxiv : the Preprint Server for Biology|June 22, 2026
Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccineJacob Berrigan, Stephanie R Monticelli, Pieter Spealman, et al.
Science Translational Medicine|February 19, 2025
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadFelix Pahmeier, Stephanie R Monticelli, Xinyi Feng, et al.
Mbio|April 16, 2025
Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virusAlbert Wang, Stephanie R Monticelli, Ariel S Wirchnianski, et al.
Nature Structural & Molecular Biology|March 6, 2019
Structural basis of broad ebolavirus neutralization by a human survivor antibodyBrandyn R West, Anna Z Wec, Crystal L Moyer, et al.
Oncotarget|November 17, 2016
Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patientsDoreen O Jackson, Kevin Byrd, Timothy J Vreeland, et al.
Elife|December 25, 2015
Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in batsMelinda Ng, Esther Ndungo, Maria E Kaczmarek, et al.
Clinical and Experimental Dermatology|July 20, 2019
Lessons learned from the development of a hidradenitis suppurativa xenograft mouse modelQ Q Quartey, R J Miller, B L Pinsker, et al.
Journal of Virology|October 16, 2015
Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus GlycoproteinZhen-Yong Keck, Sven G Enterlein, Katie A Howell, et al.
Viruses|February 26, 2022
Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced IndividualsSusan L Uprichard, Amornrat O'Brien, Monika Evdokimova, et al.
Science (New York, N.Y.)|September 10, 2016
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesAnna Z Wec, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Pageof 27

Showing results (231-240 of 269) with videos related to

Sort By:
Pageof 27
Biorxiv : the Preprint Server for Biology|June 22, 2026
Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccineJacob Berrigan, Stephanie R Monticelli, Pieter Spealman, et al.
Science Translational Medicine|February 19, 2025
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadFelix Pahmeier, Stephanie R Monticelli, Xinyi Feng, et al.
Mbio|April 16, 2025
Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virusAlbert Wang, Stephanie R Monticelli, Ariel S Wirchnianski, et al.
Nature Structural & Molecular Biology|March 6, 2019
Structural basis of broad ebolavirus neutralization by a human survivor antibodyBrandyn R West, Anna Z Wec, Crystal L Moyer, et al.
Oncotarget|November 17, 2016
Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patientsDoreen O Jackson, Kevin Byrd, Timothy J Vreeland, et al.
Elife|December 25, 2015
Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in batsMelinda Ng, Esther Ndungo, Maria E Kaczmarek, et al.
Clinical and Experimental Dermatology|July 20, 2019
Lessons learned from the development of a hidradenitis suppurativa xenograft mouse modelQ Q Quartey, R J Miller, B L Pinsker, et al.
Journal of Virology|October 16, 2015
Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus GlycoproteinZhen-Yong Keck, Sven G Enterlein, Katie A Howell, et al.
Viruses|February 26, 2022
Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced IndividualsSusan L Uprichard, Amornrat O'Brien, Monika Evdokimova, et al.
Science (New York, N.Y.)|September 10, 2016
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesAnna Z Wec, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Pageof 27